Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tetralogy of Fallot | 31 | 2024 | 631 | 6.970 |
Why?
|
Heart Defects, Congenital | 69 | 2024 | 4668 | 5.040 |
Why?
|
Pregnancy Complications, Cardiovascular | 16 | 2024 | 516 | 3.210 |
Why?
|
Fontan Procedure | 27 | 2024 | 791 | 2.840 |
Why?
|
Ventricular Dysfunction, Right | 16 | 2024 | 615 | 2.620 |
Why?
|
Pulmonary Valve | 9 | 2023 | 414 | 2.600 |
Why?
|
Magnetic Resonance Imaging, Cine | 15 | 2024 | 1038 | 2.040 |
Why?
|
Ventricular Function, Right | 12 | 2024 | 610 | 1.930 |
Why?
|
Tachycardia, Ventricular | 8 | 2023 | 1302 | 1.540 |
Why?
|
Cardiac Surgical Procedures | 17 | 2024 | 3618 | 1.490 |
Why?
|
Heart Valve Prosthesis Implantation | 7 | 2021 | 1583 | 1.140 |
Why?
|
Cardiology | 13 | 2023 | 1723 | 1.090 |
Why?
|
Pulmonary Valve Insufficiency | 6 | 2021 | 143 | 1.060 |
Why?
|
Heart Ventricles | 14 | 2024 | 3811 | 0.980 |
Why?
|
Eisenmenger Complex | 2 | 2015 | 26 | 0.930 |
Why?
|
Ebstein Anomaly | 2 | 2023 | 101 | 0.920 |
Why?
|
Heart Failure | 12 | 2023 | 11835 | 0.890 |
Why?
|
Heart Valve Prosthesis | 7 | 2020 | 1494 | 0.880 |
Why?
|
Exercise Test | 10 | 2020 | 2125 | 0.780 |
Why?
|
Tricuspid Valve Insufficiency | 3 | 2023 | 355 | 0.770 |
Why?
|
Ventricular Dysfunction, Left | 7 | 2024 | 2129 | 0.740 |
Why?
|
Heart Valve Diseases | 4 | 2023 | 1047 | 0.730 |
Why?
|
Patient Care Management | 2 | 2021 | 303 | 0.710 |
Why?
|
Heart Septal Defects, Ventricular | 2 | 2023 | 491 | 0.710 |
Why?
|
Venous Insufficiency | 2 | 2011 | 111 | 0.670 |
Why?
|
Registries | 9 | 2024 | 8449 | 0.660 |
Why?
|
Hemodynamics | 13 | 2023 | 4169 | 0.650 |
Why?
|
Pregnancy Complications, Hematologic | 2 | 2020 | 177 | 0.640 |
Why?
|
Ventricular Remodeling | 6 | 2018 | 1259 | 0.640 |
Why?
|
Cardiac Imaging Techniques | 4 | 2015 | 269 | 0.630 |
Why?
|
Thromboembolism | 3 | 2023 | 1016 | 0.620 |
Why?
|
Ventricular Function, Left | 9 | 2021 | 3870 | 0.590 |
Why?
|
Pulmonary Valve Stenosis | 1 | 2018 | 172 | 0.590 |
Why?
|
Adult | 111 | 2024 | 219847 | 0.590 |
Why?
|
Scimitar Syndrome | 2 | 2014 | 31 | 0.590 |
Why?
|
Postoperative Complications | 13 | 2023 | 15680 | 0.580 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2013 | 853 | 0.580 |
Why?
|
Aortic Coarctation | 4 | 2016 | 282 | 0.570 |
Why?
|
Blalock-Taussig Procedure | 1 | 2017 | 60 | 0.560 |
Why?
|
Young Adult | 62 | 2024 | 58673 | 0.550 |
Why?
|
Stroke Volume | 9 | 2024 | 5513 | 0.540 |
Why?
|
Magnetic Resonance Imaging | 22 | 2023 | 36247 | 0.540 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2017 | 354 | 0.520 |
Why?
|
Pregnancy | 32 | 2024 | 29725 | 0.500 |
Why?
|
Humans | 179 | 2024 | 760261 | 0.490 |
Why?
|
Societies, Medical | 4 | 2023 | 3903 | 0.480 |
Why?
|
Child Nutrition Disorders | 1 | 2016 | 150 | 0.480 |
Why?
|
Myocardial Ischemia | 3 | 2020 | 2161 | 0.450 |
Why?
|
Arrhythmias, Cardiac | 6 | 2024 | 2255 | 0.440 |
Why?
|
Clinical Protocols | 1 | 2019 | 1439 | 0.440 |
Why?
|
Adolescent | 59 | 2024 | 87747 | 0.440 |
Why?
|
Cardiovascular Agents | 2 | 2020 | 864 | 0.440 |
Why?
|
Echocardiography | 11 | 2020 | 4980 | 0.430 |
Why?
|
Female | 118 | 2024 | 391011 | 0.400 |
Why?
|
Liver Cirrhosis | 7 | 2021 | 1925 | 0.390 |
Why?
|
Pulmonary Artery | 8 | 2019 | 1919 | 0.380 |
Why?
|
Transposition of Great Vessels | 4 | 2018 | 590 | 0.370 |
Why?
|
Electrocardiography | 8 | 2024 | 6413 | 0.370 |
Why?
|
Anxiety | 2 | 2024 | 4532 | 0.360 |
Why?
|
Cardiomyopathy, Hypertrophic | 3 | 2018 | 1300 | 0.360 |
Why?
|
Arterio-Arterial Fistula | 1 | 2010 | 20 | 0.360 |
Why?
|
Sarcomeres | 1 | 2013 | 367 | 0.360 |
Why?
|
Blood Vessel Prosthesis | 1 | 2015 | 945 | 0.350 |
Why?
|
Data Collection | 3 | 2015 | 3317 | 0.350 |
Why?
|
Exercise Tolerance | 4 | 2018 | 826 | 0.350 |
Why?
|
American Heart Association | 7 | 2023 | 1081 | 0.340 |
Why?
|
Brachiocephalic Trunk | 1 | 2009 | 41 | 0.340 |
Why?
|
Predictive Value of Tests | 23 | 2024 | 15273 | 0.330 |
Why?
|
Patient Compliance | 1 | 2019 | 2689 | 0.320 |
Why?
|
Risk Factors | 37 | 2024 | 74269 | 0.320 |
Why?
|
Delivery, Obstetric | 3 | 2020 | 933 | 0.320 |
Why?
|
Hypertension, Pulmonary | 2 | 2019 | 1570 | 0.320 |
Why?
|
Vena Cava, Superior | 3 | 2014 | 197 | 0.310 |
Why?
|
Child, Preschool | 28 | 2024 | 42034 | 0.310 |
Why?
|
Follow-Up Studies | 22 | 2024 | 39254 | 0.310 |
Why?
|
Postnatal Care | 3 | 2020 | 260 | 0.310 |
Why?
|
Hypertrophy, Right Ventricular | 3 | 2018 | 107 | 0.300 |
Why?
|
Retrospective Studies | 45 | 2024 | 80301 | 0.300 |
Why?
|
Coronary Vessels | 3 | 2015 | 3112 | 0.290 |
Why?
|
Child Welfare | 2 | 2001 | 517 | 0.290 |
Why?
|
Vascular Surgical Procedures | 2 | 2013 | 1469 | 0.280 |
Why?
|
Hematologic Agents | 2 | 2019 | 41 | 0.280 |
Why?
|
Echocardiography, Doppler | 5 | 2018 | 900 | 0.280 |
Why?
|
Treatment Outcome | 30 | 2023 | 64947 | 0.280 |
Why?
|
Patient Education as Topic | 3 | 2015 | 2311 | 0.280 |
Why?
|
Pregnancy Outcome | 9 | 2021 | 2906 | 0.280 |
Why?
|
Magnetic Resonance Angiography | 4 | 2015 | 1430 | 0.280 |
Why?
|
Coronary Thrombosis | 1 | 2010 | 486 | 0.280 |
Why?
|
Male | 90 | 2024 | 359413 | 0.280 |
Why?
|
Consensus | 5 | 2023 | 3106 | 0.270 |
Why?
|
Stents | 2 | 2015 | 3303 | 0.270 |
Why?
|
Endocarditis, Bacterial | 2 | 2013 | 445 | 0.260 |
Why?
|
Heart Diseases | 4 | 2021 | 2809 | 0.260 |
Why?
|
Myocardium | 4 | 2018 | 4688 | 0.260 |
Why?
|
Infant | 23 | 2020 | 36030 | 0.260 |
Why?
|
Child | 39 | 2024 | 79758 | 0.260 |
Why?
|
Pulmonary Embolism | 2 | 2018 | 2544 | 0.260 |
Why?
|
Embolization, Therapeutic | 1 | 2015 | 1411 | 0.250 |
Why?
|
Heart Transplantation | 5 | 2023 | 3217 | 0.250 |
Why?
|
Survivors | 2 | 2024 | 2367 | 0.250 |
Why?
|
Infant, Newborn | 19 | 2022 | 26168 | 0.240 |
Why?
|
Tricuspid Atresia | 2 | 2014 | 37 | 0.230 |
Why?
|
Risk Adjustment | 2 | 2020 | 601 | 0.230 |
Why?
|
Oxygen | 1 | 2015 | 4189 | 0.230 |
Why?
|
Mentors | 3 | 2019 | 662 | 0.230 |
Why?
|
Pre-Eclampsia | 1 | 2013 | 1230 | 0.230 |
Why?
|
Patient Participation | 1 | 2013 | 1437 | 0.230 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2007 | 461 | 0.220 |
Why?
|
Pregnancy Complications | 5 | 2020 | 2940 | 0.220 |
Why?
|
Lower Extremity | 1 | 2011 | 1196 | 0.220 |
Why?
|
Propensity Score | 2 | 2023 | 1918 | 0.210 |
Why?
|
Aorta, Thoracic | 1 | 2009 | 1097 | 0.210 |
Why?
|
Breast Feeding | 2 | 2023 | 1356 | 0.210 |
Why?
|
Heart Function Tests | 3 | 2019 | 319 | 0.210 |
Why?
|
Middle Aged | 49 | 2021 | 220175 | 0.210 |
Why?
|
Cohort Studies | 18 | 2023 | 41317 | 0.210 |
Why?
|
Ascites | 2 | 2021 | 338 | 0.210 |
Why?
|
Cardiovascular Diseases | 10 | 2023 | 15740 | 0.210 |
Why?
|
Sulfonamides | 1 | 2012 | 1973 | 0.200 |
Why?
|
Myocardial Perfusion Imaging | 2 | 2019 | 572 | 0.200 |
Why?
|
Pericarditis | 1 | 2023 | 135 | 0.200 |
Why?
|
Prospective Studies | 20 | 2023 | 54263 | 0.200 |
Why?
|
Time Factors | 18 | 2024 | 40133 | 0.200 |
Why?
|
Exercise | 5 | 2023 | 5783 | 0.190 |
Why?
|
Anticoagulants | 2 | 2016 | 4896 | 0.190 |
Why?
|
Dilatation, Pathologic | 3 | 2019 | 527 | 0.190 |
Why?
|
Liver Transplantation | 2 | 2023 | 2317 | 0.190 |
Why?
|
Blood Pressure | 3 | 2013 | 8523 | 0.190 |
Why?
|
Coronary Vessel Anomalies | 3 | 2016 | 316 | 0.190 |
Why?
|
Tricuspid Valve | 1 | 2023 | 409 | 0.180 |
Why?
|
Truncus Arteriosus, Persistent | 1 | 2020 | 63 | 0.180 |
Why?
|
Thrombophilia | 2 | 2020 | 307 | 0.180 |
Why?
|
Hepatic Encephalopathy | 1 | 2021 | 142 | 0.170 |
Why?
|
Classification | 1 | 2020 | 127 | 0.170 |
Why?
|
Evidence-Based Medicine | 3 | 2019 | 3696 | 0.170 |
Why?
|
Practice Guidelines as Topic | 5 | 2021 | 7468 | 0.170 |
Why?
|
Portugal | 2 | 2016 | 90 | 0.170 |
Why?
|
Tomography, X-Ray Computed | 10 | 2020 | 20484 | 0.170 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2006 | 819 | 0.170 |
Why?
|
Liver Diseases | 2 | 2023 | 1301 | 0.170 |
Why?
|
Gadolinium | 3 | 2010 | 959 | 0.170 |
Why?
|
Prognosis | 14 | 2018 | 29636 | 0.170 |
Why?
|
Career Choice | 2 | 2017 | 755 | 0.170 |
Why?
|
Disease Management | 3 | 2019 | 2508 | 0.170 |
Why?
|
Cause of Death | 4 | 2024 | 3723 | 0.170 |
Why?
|
Bioprosthesis | 2 | 2014 | 599 | 0.160 |
Why?
|
Age Factors | 10 | 2019 | 18415 | 0.160 |
Why?
|
Turner Syndrome | 1 | 2020 | 130 | 0.160 |
Why?
|
Connective Tissue Diseases | 2 | 2019 | 286 | 0.160 |
Why?
|
Risk Assessment | 14 | 2024 | 24086 | 0.160 |
Why?
|
Cesarean Section | 4 | 2020 | 1386 | 0.160 |
Why?
|
Prenatal Care | 3 | 2023 | 1128 | 0.160 |
Why?
|
Prevalence | 15 | 2021 | 15687 | 0.160 |
Why?
|
Teratogens | 1 | 2019 | 117 | 0.160 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 3967 | 0.150 |
Why?
|
Sinus of Valsalva | 2 | 2016 | 60 | 0.150 |
Why?
|
Cross-Sectional Studies | 14 | 2020 | 25928 | 0.150 |
Why?
|
Breathing Exercises | 1 | 2018 | 60 | 0.150 |
Why?
|
Inhalation | 1 | 2018 | 143 | 0.150 |
Why?
|
Respiratory Muscles | 1 | 2018 | 142 | 0.150 |
Why?
|
Congresses as Topic | 3 | 2018 | 804 | 0.150 |
Why?
|
Bacteremia | 1 | 2004 | 979 | 0.150 |
Why?
|
Coronary Angiography | 5 | 2016 | 4560 | 0.150 |
Why?
|
Canada | 2 | 2013 | 2128 | 0.140 |
Why?
|
Private Sector | 1 | 2020 | 398 | 0.140 |
Why?
|
Arteriosclerosis | 1 | 2001 | 1064 | 0.140 |
Why?
|
Anesthetics | 1 | 2022 | 522 | 0.140 |
Why?
|
Equipment Design | 2 | 2015 | 3520 | 0.140 |
Why?
|
Hyperlipidemias | 1 | 2001 | 782 | 0.130 |
Why?
|
Diabetic Ketoacidosis | 1 | 2020 | 257 | 0.130 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 2 | 2016 | 323 | 0.130 |
Why?
|
Europe | 2 | 2013 | 3433 | 0.130 |
Why?
|
Contrast Media | 5 | 2018 | 5301 | 0.130 |
Why?
|
Stainless Steel | 1 | 2015 | 79 | 0.130 |
Why?
|
Staphylococcal Infections | 1 | 2004 | 1405 | 0.130 |
Why?
|
Observer Variation | 4 | 2020 | 2596 | 0.130 |
Why?
|
Standard of Care | 1 | 2019 | 552 | 0.130 |
Why?
|
Atrial Fibrillation | 3 | 2023 | 5201 | 0.130 |
Why?
|
Cardiac Volume | 2 | 2013 | 199 | 0.130 |
Why?
|
Tooth, Impacted | 1 | 2015 | 43 | 0.120 |
Why?
|
Molar, Third | 1 | 2015 | 53 | 0.120 |
Why?
|
Pacemaker, Artificial | 2 | 2011 | 815 | 0.120 |
Why?
|
Diastole | 2 | 2018 | 788 | 0.120 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2019 | 1067 | 0.120 |
Why?
|
Hospitalization | 5 | 2023 | 10761 | 0.120 |
Why?
|
Education, Medical, Graduate | 2 | 2023 | 2359 | 0.120 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2015 | 192 | 0.120 |
Why?
|
United States | 17 | 2023 | 72363 | 0.120 |
Why?
|
Anticholesteremic Agents | 1 | 2001 | 988 | 0.110 |
Why?
|
Tooth Extraction | 1 | 2015 | 229 | 0.110 |
Why?
|
Multivariate Analysis | 10 | 2018 | 12156 | 0.110 |
Why?
|
Galectin 3 | 1 | 2016 | 240 | 0.110 |
Why?
|
Death | 1 | 2018 | 678 | 0.110 |
Why?
|
Cardiac Care Facilities | 1 | 2013 | 34 | 0.110 |
Why?
|
Hypertension | 1 | 2013 | 8595 | 0.110 |
Why?
|
Kidney Calculi | 1 | 1997 | 468 | 0.110 |
Why?
|
Stress, Psychological | 3 | 2024 | 4440 | 0.110 |
Why?
|
Ventricular Septal Rupture | 1 | 2013 | 17 | 0.110 |
Why?
|
Angina Pectoris | 4 | 1993 | 969 | 0.110 |
Why?
|
Fibrinolytic Agents | 2 | 2020 | 2167 | 0.110 |
Why?
|
Myocardial Infarction | 4 | 2013 | 11891 | 0.110 |
Why?
|
Hyaluronic Acid | 1 | 2016 | 482 | 0.110 |
Why?
|
Biological Specimen Banks | 1 | 2018 | 776 | 0.110 |
Why?
|
Pulmonary Veno-Occlusive Disease | 1 | 2013 | 64 | 0.100 |
Why?
|
Databases, Factual | 6 | 2021 | 8018 | 0.100 |
Why?
|
Automation | 1 | 2015 | 581 | 0.100 |
Why?
|
Pediatrics | 3 | 2015 | 3587 | 0.100 |
Why?
|
Heart Rate | 3 | 2014 | 4169 | 0.100 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2018 | 594 | 0.100 |
Why?
|
Fetus | 2 | 2016 | 1859 | 0.100 |
Why?
|
Curriculum | 2 | 2023 | 3722 | 0.100 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2012 | 119 | 0.100 |
Why?
|
Patient Selection | 3 | 2020 | 4276 | 0.100 |
Why?
|
Liver | 4 | 2016 | 7512 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2024 | 2297 | 0.100 |
Why?
|
Clinical Competence | 3 | 2023 | 4786 | 0.100 |
Why?
|
Sarcopenia | 1 | 2016 | 372 | 0.100 |
Why?
|
Cost of Illness | 1 | 2021 | 1940 | 0.100 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2014 | 504 | 0.090 |
Why?
|
Spinal Cord | 2 | 1999 | 1817 | 0.090 |
Why?
|
Anesthesia | 1 | 2022 | 1584 | 0.090 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2016 | 3335 | 0.090 |
Why?
|
Hospital Costs | 1 | 2017 | 976 | 0.090 |
Why?
|
Astrocytes | 1 | 1999 | 1335 | 0.090 |
Why?
|
Pulmonary Circulation | 4 | 2018 | 743 | 0.090 |
Why?
|
Women's Health | 1 | 2020 | 2057 | 0.090 |
Why?
|
Radiation Dosage | 1 | 2019 | 1957 | 0.090 |
Why?
|
Hemorrhage | 2 | 2020 | 3604 | 0.090 |
Why?
|
Advisory Committees | 1 | 2015 | 789 | 0.090 |
Why?
|
Faculty, Medical | 1 | 2019 | 1192 | 0.090 |
Why?
|
Multicenter Studies as Topic | 2 | 2022 | 1723 | 0.090 |
Why?
|
Coronary Artery Disease | 3 | 2021 | 6661 | 0.090 |
Why?
|
Delayed Diagnosis | 1 | 2014 | 463 | 0.090 |
Why?
|
Hernia, Diaphragmatic | 1 | 2011 | 246 | 0.090 |
Why?
|
Critical Care | 1 | 2023 | 2699 | 0.090 |
Why?
|
Disease Progression | 6 | 2018 | 13505 | 0.090 |
Why?
|
Electric Countershock | 1 | 2013 | 537 | 0.080 |
Why?
|
Survival Analysis | 4 | 2018 | 10185 | 0.080 |
Why?
|
Heart Block | 1 | 2011 | 392 | 0.080 |
Why?
|
Heart Septum | 1 | 2010 | 303 | 0.080 |
Why?
|
Italy | 3 | 2021 | 840 | 0.080 |
Why?
|
Elasticity Imaging Techniques | 1 | 2014 | 389 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1819 | 0.080 |
Why?
|
Radiography | 5 | 2013 | 6965 | 0.080 |
Why?
|
Dobutamine | 1 | 2009 | 116 | 0.080 |
Why?
|
Pilot Projects | 3 | 2023 | 8553 | 0.080 |
Why?
|
Chronic Disease | 2 | 2016 | 9283 | 0.080 |
Why?
|
End Stage Liver Disease | 1 | 2013 | 347 | 0.080 |
Why?
|
Intraoperative Complications | 1 | 2015 | 1186 | 0.080 |
Why?
|
Biomedical Research | 3 | 2018 | 3421 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2024 | 4317 | 0.080 |
Why?
|
Acute Disease | 2 | 2016 | 7268 | 0.080 |
Why?
|
Radiography, Thoracic | 1 | 2014 | 1295 | 0.070 |
Why?
|
Prosthesis-Related Infections | 1 | 2013 | 486 | 0.070 |
Why?
|
Insurance, Health | 1 | 2020 | 2500 | 0.070 |
Why?
|
ROC Curve | 4 | 2018 | 3568 | 0.070 |
Why?
|
Postoperative Period | 1 | 2012 | 1821 | 0.070 |
Why?
|
Ventricular Function | 1 | 2009 | 408 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2001 | 3960 | 0.070 |
Why?
|
Preoperative Care | 2 | 2015 | 2255 | 0.070 |
Why?
|
Heart | 3 | 2020 | 4392 | 0.070 |
Why?
|
Pulmonary Veins | 1 | 2013 | 745 | 0.070 |
Why?
|
Cardiomyopathies | 2 | 2019 | 1945 | 0.070 |
Why?
|
Education, Medical | 1 | 2019 | 1728 | 0.070 |
Why?
|
Osteoporosis | 1 | 2016 | 1600 | 0.070 |
Why?
|
Aortic Diseases | 1 | 2012 | 736 | 0.070 |
Why?
|
Electrodes, Implanted | 1 | 2011 | 833 | 0.070 |
Why?
|
C-Reactive Protein | 1 | 2018 | 3822 | 0.070 |
Why?
|
Models, Cardiovascular | 1 | 2012 | 974 | 0.070 |
Why?
|
Thrombosis | 1 | 2020 | 3052 | 0.070 |
Why?
|
Heterozygote | 1 | 2013 | 2797 | 0.070 |
Why?
|
Fibrosis | 3 | 2018 | 2042 | 0.070 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15827 | 0.070 |
Why?
|
Fellowships and Scholarships | 1 | 2015 | 1118 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2021 | 3764 | 0.070 |
Why?
|
Diagnosis, Differential | 4 | 2013 | 12968 | 0.070 |
Why?
|
Calcinosis | 1 | 2015 | 1478 | 0.070 |
Why?
|
Continuity of Patient Care | 1 | 2013 | 1067 | 0.060 |
Why?
|
Stem Cells | 1 | 1999 | 3525 | 0.060 |
Why?
|
Physicians | 2 | 2014 | 4590 | 0.060 |
Why?
|
Cardiotonic Agents | 1 | 2009 | 546 | 0.060 |
Why?
|
Depression | 2 | 2024 | 8033 | 0.060 |
Why?
|
Angiography | 3 | 2020 | 1605 | 0.060 |
Why?
|
Anesthesia, Obstetrical | 1 | 2008 | 233 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 3 | 2015 | 4044 | 0.060 |
Why?
|
Reoperation | 4 | 2020 | 4292 | 0.060 |
Why?
|
Leg | 1 | 2010 | 1091 | 0.060 |
Why?
|
Liver Function Tests | 2 | 2016 | 524 | 0.060 |
Why?
|
Heat-Shock Proteins | 1 | 2009 | 795 | 0.060 |
Why?
|
Aorta | 1 | 2012 | 2042 | 0.060 |
Why?
|
Aged | 16 | 2021 | 168995 | 0.060 |
Why?
|
Death, Sudden, Cardiac | 1 | 2013 | 1572 | 0.060 |
Why?
|
Drainage | 1 | 2010 | 1161 | 0.060 |
Why?
|
Dyspnea | 1 | 2012 | 1352 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3381 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3333 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2014 | 2753 | 0.060 |
Why?
|
Sex Factors | 4 | 2020 | 10530 | 0.050 |
Why?
|
Sexual Behavior | 1 | 2013 | 2080 | 0.050 |
Why?
|
Defibrillators, Implantable | 1 | 2013 | 1499 | 0.050 |
Why?
|
Positron-Emission Tomography | 2 | 2019 | 6457 | 0.050 |
Why?
|
Algorithms | 3 | 2019 | 13967 | 0.050 |
Why?
|
Intracranial Aneurysm | 1 | 2012 | 1276 | 0.050 |
Why?
|
Cerebrovascular Circulation | 1 | 2012 | 2731 | 0.050 |
Why?
|
Area Under Curve | 2 | 2018 | 1635 | 0.050 |
Why?
|
Mitral Valve Insufficiency | 1 | 2012 | 1419 | 0.050 |
Why?
|
Aftercare | 2 | 2020 | 918 | 0.050 |
Why?
|
Colchicine | 1 | 2023 | 261 | 0.050 |
Why?
|
Image Enhancement | 2 | 2015 | 2877 | 0.050 |
Why?
|
Prone Position | 1 | 2003 | 196 | 0.050 |
Why?
|
Erysipelas | 1 | 2000 | 3 | 0.050 |
Why?
|
Adolescent Medicine | 1 | 2001 | 73 | 0.050 |
Why?
|
Heart-Assist Devices | 1 | 2012 | 1290 | 0.050 |
Why?
|
Survival Rate | 5 | 2020 | 12806 | 0.050 |
Why?
|
Catheter Ablation | 1 | 2014 | 2755 | 0.050 |
Why?
|
Venous Thrombosis | 1 | 2010 | 1293 | 0.050 |
Why?
|
Linear Models | 3 | 2016 | 5876 | 0.050 |
Why?
|
Anesthesia, General | 1 | 2008 | 1165 | 0.050 |
Why?
|
Gestational Age | 3 | 2020 | 3564 | 0.040 |
Why?
|
Incidence | 5 | 2021 | 21378 | 0.040 |
Why?
|
Pulmonary Atresia | 2 | 2012 | 159 | 0.040 |
Why?
|
Diet Therapy | 1 | 2001 | 151 | 0.040 |
Why?
|
Reproducibility of Results | 5 | 2024 | 20048 | 0.040 |
Why?
|
Logistic Models | 4 | 2018 | 13311 | 0.040 |
Why?
|
Health Status | 1 | 2013 | 4081 | 0.040 |
Why?
|
Reference Values | 3 | 2015 | 4920 | 0.040 |
Why?
|
Radionuclide Imaging | 3 | 2009 | 1975 | 0.040 |
Why?
|
Sudden Infant Death | 1 | 2003 | 291 | 0.040 |
Why?
|
Educational Measurement | 2 | 2019 | 1249 | 0.040 |
Why?
|
Internship and Residency | 2 | 2015 | 5867 | 0.040 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2024 | 784 | 0.040 |
Why?
|
Obesity | 2 | 2001 | 12915 | 0.040 |
Why?
|
Extraction, Obstetrical | 1 | 2019 | 28 | 0.040 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 1999 | 1746 | 0.040 |
Why?
|
Heart Atria | 2 | 2018 | 1344 | 0.040 |
Why?
|
Piperidines | 1 | 2008 | 1650 | 0.040 |
Why?
|
Valsalva Maneuver | 1 | 2019 | 98 | 0.040 |
Why?
|
Statistics, Nonparametric | 2 | 2016 | 2852 | 0.040 |
Why?
|
Inspiratory Capacity | 1 | 2018 | 35 | 0.040 |
Why?
|
Carps | 1 | 1998 | 51 | 0.040 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2011 | 2160 | 0.040 |
Why?
|
Trout | 1 | 1998 | 20 | 0.040 |
Why?
|
Oxygen Consumption | 2 | 2018 | 1840 | 0.040 |
Why?
|
Chemoprevention | 1 | 2020 | 326 | 0.040 |
Why?
|
Computer Simulation | 1 | 2012 | 6210 | 0.040 |
Why?
|
Boston | 3 | 2018 | 9282 | 0.040 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 1999 | 137 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2015 | 4763 | 0.040 |
Why?
|
Cryptorchidism | 1 | 1998 | 151 | 0.040 |
Why?
|
Morbidity | 1 | 2023 | 1765 | 0.040 |
Why?
|
Hypothyroidism | 1 | 2002 | 665 | 0.040 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 1999 | 550 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2020 | 58947 | 0.030 |
Why?
|
Chick Embryo | 1 | 1999 | 981 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2024 | 22041 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2013 | 14482 | 0.030 |
Why?
|
Kentucky | 1 | 2016 | 84 | 0.030 |
Why?
|
Chickens | 1 | 1999 | 859 | 0.030 |
Why?
|
Postmenopause | 1 | 2006 | 2503 | 0.030 |
Why?
|
New England | 1 | 2019 | 1045 | 0.030 |
Why?
|
Staphylococcus aureus | 1 | 2004 | 1462 | 0.030 |
Why?
|
Ureteroscopy | 1 | 1997 | 148 | 0.030 |
Why?
|
Research Design | 1 | 2012 | 6181 | 0.030 |
Why?
|
Neurofilament Proteins | 1 | 1998 | 333 | 0.030 |
Why?
|
Preservatives, Pharmaceutical | 1 | 2015 | 34 | 0.030 |
Why?
|
Postpartum Hemorrhage | 1 | 2019 | 265 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2016 | 11064 | 0.030 |
Why?
|
Japan | 1 | 2020 | 1369 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2020 | 12281 | 0.030 |
Why?
|
Prosthesis Design | 2 | 2013 | 2127 | 0.030 |
Why?
|
Body Mass Index | 3 | 2016 | 12901 | 0.030 |
Why?
|
Proteomics | 1 | 2009 | 3810 | 0.030 |
Why?
|
Fatigue | 1 | 2002 | 1544 | 0.030 |
Why?
|
Cardiomegaly | 1 | 2018 | 593 | 0.030 |
Why?
|
Biopsy | 3 | 2016 | 6775 | 0.030 |
Why?
|
Dehydration | 1 | 2016 | 226 | 0.030 |
Why?
|
Anesthesia, Dental | 1 | 2015 | 64 | 0.030 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2014 | 578 | 0.030 |
Why?
|
Cardiac Valve Annuloplasty | 1 | 2015 | 51 | 0.030 |
Why?
|
Single-Blind Method | 2 | 2009 | 1577 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2020 | 966 | 0.030 |
Why?
|
Species Specificity | 1 | 1999 | 2413 | 0.030 |
Why?
|
Treatment Failure | 2 | 2012 | 2646 | 0.030 |
Why?
|
Spermatozoa | 1 | 1998 | 631 | 0.030 |
Why?
|
Abruptio Placentae | 1 | 2015 | 118 | 0.030 |
Why?
|
International Cooperation | 1 | 2020 | 1436 | 0.030 |
Why?
|
Hepatitis, Alcoholic | 1 | 1996 | 109 | 0.030 |
Why?
|
Lymphedema | 1 | 2000 | 525 | 0.030 |
Why?
|
Meglumine | 1 | 2014 | 145 | 0.030 |
Why?
|
Hepatitis | 1 | 1996 | 231 | 0.030 |
Why?
|
Antiphospholipid Syndrome | 1 | 2015 | 165 | 0.030 |
Why?
|
Recurrence | 2 | 2023 | 8487 | 0.030 |
Why?
|
Clinical Coding | 1 | 2015 | 181 | 0.030 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2014 | 140 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2023 | 2282 | 0.030 |
Why?
|
Competency-Based Education | 1 | 2015 | 218 | 0.030 |
Why?
|
Maternal-Fetal Exchange | 1 | 2015 | 463 | 0.030 |
Why?
|
Research Support as Topic | 1 | 2017 | 699 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2007 | 3526 | 0.030 |
Why?
|
Infant, Premature, Diseases | 1 | 1999 | 708 | 0.030 |
Why?
|
Radiopharmaceuticals | 2 | 2019 | 2633 | 0.030 |
Why?
|
Galectins | 1 | 2016 | 282 | 0.030 |
Why?
|
Smoking | 1 | 2010 | 9070 | 0.030 |
Why?
|
Thinness | 1 | 2016 | 491 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 2018 | 730 | 0.030 |
Why?
|
Coronary Disease | 3 | 1992 | 5993 | 0.030 |
Why?
|
Patient Advocacy | 1 | 2015 | 358 | 0.030 |
Why?
|
Gadolinium DTPA | 1 | 2015 | 826 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2013 | 6545 | 0.030 |
Why?
|
Venous Pressure | 1 | 2012 | 57 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2019 | 2434 | 0.030 |
Why?
|
Electric Impedance | 1 | 2016 | 751 | 0.030 |
Why?
|
Ohio | 1 | 2012 | 333 | 0.030 |
Why?
|
Ultrasonography, Prenatal | 1 | 2020 | 1745 | 0.020 |
Why?
|
Chi-Square Distribution | 2 | 2015 | 3466 | 0.020 |
Why?
|
Odds Ratio | 2 | 2015 | 9712 | 0.020 |
Why?
|
Language | 1 | 2021 | 1532 | 0.020 |
Why?
|
Myocardial Revascularization | 1 | 2016 | 841 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2008 | 3762 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1870 | 0.020 |
Why?
|
Inpatients | 1 | 2023 | 2578 | 0.020 |
Why?
|
History, 21st Century | 1 | 2018 | 1576 | 0.020 |
Why?
|
Fetal Growth Retardation | 1 | 2015 | 579 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2014 | 1628 | 0.020 |
Why?
|
Ultrasonography | 3 | 2013 | 5960 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2015 | 983 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2015 | 1098 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2016 | 1666 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2014 | 1490 | 0.020 |
Why?
|
Aspirin | 1 | 2023 | 3365 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2016 | 1633 | 0.020 |
Why?
|
Bilirubin | 1 | 2013 | 438 | 0.020 |
Why?
|
Sternotomy | 1 | 2012 | 127 | 0.020 |
Why?
|
Autopsy | 1 | 2015 | 1007 | 0.020 |
Why?
|
Liver Circulation | 1 | 2011 | 159 | 0.020 |
Why?
|
Massachusetts | 2 | 2015 | 8805 | 0.020 |
Why?
|
Isosorbide Dinitrate | 1 | 1990 | 37 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1673 | 0.020 |
Why?
|
Netherlands | 1 | 2015 | 2213 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2931 | 0.020 |
Why?
|
Skull Fractures | 1 | 1992 | 201 | 0.020 |
Why?
|
Intensive Care Units, Neonatal | 1 | 1997 | 833 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 2014 | 659 | 0.020 |
Why?
|
Blood Proteins | 1 | 2016 | 1172 | 0.020 |
Why?
|
Sensitivity and Specificity | 3 | 2015 | 14656 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2249 | 0.020 |
Why?
|
Nifedipine | 1 | 1990 | 221 | 0.020 |
Why?
|
Axons | 1 | 1998 | 1672 | 0.020 |
Why?
|
Sympathetic Nervous System | 1 | 1993 | 519 | 0.020 |
Why?
|
Mortality | 1 | 2021 | 2916 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2007 | 8945 | 0.020 |
Why?
|
Weight Loss | 1 | 2001 | 2683 | 0.020 |
Why?
|
Autoantibodies | 1 | 1998 | 2119 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3929 | 0.020 |
Why?
|
Radiology | 1 | 2023 | 2103 | 0.020 |
Why?
|
Goals | 1 | 2015 | 708 | 0.020 |
Why?
|
Protein-Losing Enteropathies | 1 | 2009 | 45 | 0.020 |
Why?
|
Fatty Liver | 1 | 1996 | 777 | 0.020 |
Why?
|
Tachycardia, Atrioventricular Nodal Reentry | 1 | 2010 | 149 | 0.020 |
Why?
|
Thoracotomy | 1 | 2011 | 362 | 0.020 |
Why?
|
Leadership | 1 | 2019 | 1372 | 0.020 |
Why?
|
Collateral Circulation | 1 | 1990 | 292 | 0.020 |
Why?
|
Cerebellar Neoplasms | 1 | 1994 | 585 | 0.020 |
Why?
|
Vascular Resistance | 1 | 2012 | 932 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 283 | 0.020 |
Why?
|
Medulloblastoma | 1 | 1994 | 677 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2014 | 1181 | 0.020 |
Why?
|
Bronchitis | 1 | 2009 | 196 | 0.020 |
Why?
|
Ventricular Dysfunction | 1 | 2009 | 145 | 0.020 |
Why?
|
Mutation | 1 | 2013 | 29950 | 0.020 |
Why?
|
Materials Testing | 1 | 2012 | 858 | 0.020 |
Why?
|
Atrial Flutter | 1 | 2010 | 258 | 0.020 |
Why?
|
Aortic Valve Insufficiency | 1 | 2012 | 584 | 0.020 |
Why?
|
Comorbidity | 2 | 2015 | 10552 | 0.020 |
Why?
|
Ligation | 1 | 2009 | 448 | 0.020 |
Why?
|
Health Care Costs | 1 | 2021 | 3257 | 0.020 |
Why?
|
Recovery of Function | 1 | 2018 | 2982 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1215 | 0.020 |
Why?
|
Angina, Unstable | 1 | 1992 | 926 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2015 | 1826 | 0.020 |
Why?
|
Teaching | 1 | 2015 | 1167 | 0.020 |
Why?
|
Creatinine | 1 | 2013 | 1906 | 0.020 |
Why?
|
Cerebral Angiography | 1 | 2012 | 1272 | 0.020 |
Why?
|
Body Composition | 1 | 2016 | 2418 | 0.020 |
Why?
|
Shock, Cardiogenic | 1 | 2013 | 734 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 2008 | 379 | 0.020 |
Why?
|
Coronary Circulation | 1 | 1993 | 1578 | 0.020 |
Why?
|
Pericardium | 1 | 2011 | 675 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4127 | 0.020 |
Why?
|
Syndrome | 1 | 1993 | 3278 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2019 | 3598 | 0.020 |
Why?
|
Arterial Occlusive Diseases | 1 | 1990 | 752 | 0.020 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2008 | 619 | 0.020 |
Why?
|
Growth Hormone | 1 | 2008 | 568 | 0.020 |
Why?
|
Echocardiography, Transesophageal | 1 | 2012 | 1108 | 0.020 |
Why?
|
Body Weight | 1 | 2016 | 4613 | 0.020 |
Why?
|
Quality of Life | 2 | 2020 | 13300 | 0.020 |
Why?
|
Tissue and Organ Harvesting | 1 | 2009 | 377 | 0.020 |
Why?
|
Qualitative Research | 1 | 2016 | 2958 | 0.020 |
Why?
|
Mass Screening | 1 | 2001 | 5422 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2001 | 8058 | 0.020 |
Why?
|
Norepinephrine | 1 | 2008 | 900 | 0.020 |
Why?
|
Motion | 1 | 2009 | 779 | 0.020 |
Why?
|
Antibodies, Monoclonal | 2 | 1999 | 9196 | 0.020 |
Why?
|
Chest Pain | 1 | 2012 | 1106 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2013 | 6242 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2012 | 1266 | 0.010 |
Why?
|
Epinephrine | 1 | 2008 | 791 | 0.010 |
Why?
|
Random Allocation | 1 | 2009 | 2394 | 0.010 |
Why?
|
Age of Onset | 1 | 2011 | 3302 | 0.010 |
Why?
|
Hospitals, Pediatric | 1 | 2013 | 1853 | 0.010 |
Why?
|
Length of Stay | 1 | 2017 | 6472 | 0.010 |
Why?
|
Probability | 1 | 2009 | 2476 | 0.010 |
Why?
|
Renal Insufficiency | 1 | 2009 | 820 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2009 | 2671 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10829 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2017 | 5420 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2015 | 3201 | 0.010 |
Why?
|
Supine Position | 1 | 2003 | 205 | 0.010 |
Why?
|
Cerebral Ventricles | 1 | 1985 | 543 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2012 | 2283 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5396 | 0.010 |
Why?
|
Calcium | 1 | 2015 | 5726 | 0.010 |
Why?
|
Patient Readmission | 1 | 2016 | 3327 | 0.010 |
Why?
|
Sampling Studies | 1 | 2003 | 614 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2016 | 4923 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2013 | 12532 | 0.010 |
Why?
|
Technetium Tc 99m Sulfur Colloid | 1 | 2000 | 63 | 0.010 |
Why?
|
Antimony | 1 | 2000 | 19 | 0.010 |
Why?
|
Animals | 4 | 2018 | 167940 | 0.010 |
Why?
|
Cognition Disorders | 1 | 2015 | 3976 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9629 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16543 | 0.010 |
Why?
|
Stress, Physiological | 1 | 2008 | 1395 | 0.010 |
Why?
|
Brain Injuries | 1 | 1992 | 2044 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2014 | 4361 | 0.010 |
Why?
|
Amniocentesis | 1 | 1999 | 115 | 0.010 |
Why?
|
Swine | 1 | 2009 | 5902 | 0.010 |
Why?
|
Work Schedule Tolerance | 1 | 2002 | 551 | 0.010 |
Why?
|
Long QT Syndrome | 1 | 2003 | 465 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2009 | 5201 | 0.010 |
Why?
|
Dilatation and Curettage | 1 | 1997 | 52 | 0.010 |
Why?
|
Heart Conduction System | 1 | 2003 | 1016 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17766 | 0.010 |
Why?
|
Pregnancy Trimester, Second | 1 | 1999 | 732 | 0.010 |
Why?
|
Cross Reactions | 1 | 1998 | 818 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1994 | 9274 | 0.010 |
Why?
|
Obstetric Labor Complications | 1 | 1997 | 236 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2003 | 1784 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1998 | 2558 | 0.010 |
Why?
|
Maternal Mortality | 1 | 1997 | 300 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2013 | 7400 | 0.010 |
Why?
|
Proteins | 1 | 2009 | 6030 | 0.010 |
Why?
|
Cranial Fossa, Posterior | 1 | 1994 | 135 | 0.010 |
Why?
|
Mammals | 1 | 1998 | 1129 | 0.010 |
Why?
|
Actuarial Analysis | 1 | 1992 | 375 | 0.010 |
Why?
|
Postoperative Care | 1 | 1998 | 1478 | 0.010 |
Why?
|
Abortion, Induced | 1 | 1997 | 460 | 0.010 |
Why?
|
Epitopes | 1 | 1998 | 2506 | 0.010 |
Why?
|
Emergencies | 1 | 1997 | 1217 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2009 | 11902 | 0.010 |
Why?
|
Blotting, Western | 1 | 1998 | 5039 | 0.010 |
Why?
|
Glasgow Coma Scale | 1 | 1992 | 579 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2009 | 18134 | 0.010 |
Why?
|
Respiratory Insufficiency | 1 | 1997 | 1228 | 0.000 |
Why?
|
Diabetes Complications | 1 | 1996 | 1342 | 0.000 |
Why?
|
Coma | 1 | 1992 | 487 | 0.000 |
Why?
|
Phosphorylation | 1 | 1998 | 8314 | 0.000 |
Why?
|
Schizophrenia | 1 | 1985 | 6915 | 0.000 |
Why?
|
Ambulatory Care | 1 | 1996 | 2783 | 0.000 |
Why?
|
Wechsler Scales | 1 | 1985 | 257 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1994 | 8551 | 0.000 |
Why?
|
Intelligence | 1 | 1985 | 919 | 0.000 |
Why?
|
Schizophrenic Psychology | 1 | 1985 | 1646 | 0.000 |
Why?
|
Neuropsychological Tests | 1 | 1985 | 7016 | 0.000 |
Why?
|
Brain | 1 | 1992 | 26912 | 0.000 |
Why?
|